Oculis
Anat Loewenstein, M.D., MHA, is Professor of Ophthalmology, Chairman of the Division of Ophthalmology at the Tel Aviv Medical Center, Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at Tel Aviv University, President of the Israeli Ophthalmological Society, and the General Secretary of the EURETINA board. She is a renowned retina specialist, expert in retinal toxicity, and has a strong research interest in the early detection of macular degeneration, among others. She currently serves as the Editor in Chief of the Journal Case Reports in Ophthalmology, is an associate editor of Investigative Ophthalmology & Visual Science Journal, European Journal of Ophthalmology and of Ophthalmologica. Pr. Loewenstein published more than 450 papers in peer reviewed journals and contributed multiple chapters to ophthalmology textbooks. She is also actively involved as a leader in mentorship of young retina specialists including the mentorship educational programs of ARVO and EURETINA.
This person is not in the org chart
This person is not in any offices
Oculis
1 followers
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back-and front-of-the-eye in order to improve the sight and the lives of patients worldwide.